334 related articles for article (PubMed ID: 27110656)
1. Natriuretic peptide-guided management in heart failure.
Chioncel O; Collins SP; Greene SJ; Ambrosy AP; Vaduganathan M; Macarie C; Butler J; Gheorghiade M
J Cardiovasc Med (Hagerstown); 2016 Aug; 17(8):556-68. PubMed ID: 27110656
[TBL] [Abstract][Full Text] [Related]
2. The role of natriuretic peptide testing in guiding chronic heart failure management: review of available data and recommendations for use.
Januzzi JL
Arch Cardiovasc Dis; 2012 Jan; 105(1):40-50. PubMed ID: 22369917
[TBL] [Abstract][Full Text] [Related]
3. Natriuretic peptide-guided heart failure management.
Troughton R; Michael Felker G; Januzzi JL
Eur Heart J; 2014 Jan; 35(1):16-24. PubMed ID: 24216390
[TBL] [Abstract][Full Text] [Related]
4. Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials.
Felker GM; Hasselblad V; Hernandez AF; O'Connor CM
Am Heart J; 2009 Sep; 158(3):422-30. PubMed ID: 19699866
[TBL] [Abstract][Full Text] [Related]
5. Natriuretic peptide-guided management of acutely destabilized heart failure: rationale and treatment algorithm.
Bhardwaj A; Januzzi JL
Crit Pathw Cardiol; 2009 Dec; 8(4):146-50. PubMed ID: 19952548
[TBL] [Abstract][Full Text] [Related]
6. Natriuretic peptide testing for heart failure therapy guidance in the inpatient and outpatient setting.
Green SM; Green JA; Januzzi JL
Am J Ther; 2009; 16(2):171-7. PubMed ID: 19300043
[TBL] [Abstract][Full Text] [Related]
7. Current and novel biomarkers in heart failure: bench to bedside.
Ghashghaei R; Arbit B; Maisel AS
Curr Opin Cardiol; 2016 Mar; 31(2):191-5. PubMed ID: 26814650
[TBL] [Abstract][Full Text] [Related]
8. Novel markers for heart failure diagnosis and prognosis.
Lee DS; Vasan RS
Curr Opin Cardiol; 2005 May; 20(3):201-10. PubMed ID: 15861008
[TBL] [Abstract][Full Text] [Related]
9. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.
Manzano-Fernández S; Boronat-Garcia M; Albaladejo-Otón MD; Pastor P; Garrido IP; Pastor-Pérez FJ; Martínez-Hernández P; Valdés M; Pascual-Figal DA
Am J Cardiol; 2009 Jun; 103(12):1753-9. PubMed ID: 19539088
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers in heart failure management.
Isaac DL
Curr Opin Cardiol; 2008 Mar; 23(2):127-33. PubMed ID: 18303525
[TBL] [Abstract][Full Text] [Related]
11. The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure.
Mair J; Hammerer-Lercher A; Puschendorf B
Clin Chem Lab Med; 2001 Jul; 39(7):571-88. PubMed ID: 11522102
[TBL] [Abstract][Full Text] [Related]
12. Brain natriuretic peptide-guided therapy in the inpatient management of decompensated heart failure.
Saremi A; Gopal D; Maisel AS
Expert Rev Cardiovasc Ther; 2012 Feb; 10(2):191-203. PubMed ID: 22292875
[TBL] [Abstract][Full Text] [Related]
13. B-type natriuretic peptide in the management of heart failure.
Maurellet JD; Liu PT
Hong Kong Med J; 2008 Jun; 14(3):216-9. PubMed ID: 18525091
[TBL] [Abstract][Full Text] [Related]
14. Rapid point-of-care NT-proBNP optimal cut-off point for heart failure diagnosis in primary care.
Verdú JM; Comín-Colet J; Domingo M; Lupón J; Gómez M; Molina L; Casacuberta JM; Muñoz MA; Mena A; Bruguera-Cortada J
Rev Esp Cardiol (Engl Ed); 2012 Jul; 65(7):613-9. PubMed ID: 22541282
[TBL] [Abstract][Full Text] [Related]
15. Combining natriuretic peptides and necrosis markers in determining prognosis in heart failure.
Fonarow GC; Horwich TB
Rev Cardiovasc Med; 2003; 4 Suppl 4():S20-8. PubMed ID: 14564225
[TBL] [Abstract][Full Text] [Related]
16. Evolution of natriuretic peptide biomarkers in heart failure: Implications for clinical care and clinical trials.
Vodovar N; Mebazaa A; Januzzi JL; Murtagh G; Stough WG; Adams KF; Zannad F
Int J Cardiol; 2018 Mar; 254():215-221. PubMed ID: 29407093
[TBL] [Abstract][Full Text] [Related]
17. The potential role of natriuretic peptides and other biomarkers in heart failure diagnosis, prognosis and management.
Ibrahim N; Januzzi JL
Expert Rev Cardiovasc Ther; 2015; 13(9):1017-30. PubMed ID: 26198476
[TBL] [Abstract][Full Text] [Related]
18. [From BNP to ST2: Which biomarkers to use in practice?].
Logeart D; Baudet M
Presse Med; 2016 Oct; 45(10):877-884. PubMed ID: 27387365
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers: Their potential in the diagnosis and treatment of heart failure.
Heil B; Tang WH
Cleve Clin J Med; 2015 Dec; 82(12 Suppl 2):S28-35. PubMed ID: 26694889
[TBL] [Abstract][Full Text] [Related]
20. Brain natriuretic peptide in the contemporary management of congestive heart failure.
Wasywich CA; Whalley GA; Doughty RN
Expert Rev Cardiovasc Ther; 2005 Jan; 3(1):71-84. PubMed ID: 15723576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
